Patents expiring in 2034

US 8911742

Transcutaneous immunization without heterologous adjuvant

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912175

Topical compositions for treatment of skin conditions

Molecular Design International, Inc. · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912146

Derivatives of APF and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912334

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912198

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912185

Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912199

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912326

Process of making gyrase and topoisomerase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912214

Use of Chk2 kinase inhibitors for cancer treatment

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2014371251

METHOD OF INHIBITING DYRK1B

4SC DISCOVERY GMBH [DE] · Granted Thu Dec 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916693

Monoconjugated chitosans as delivery agents for small interfering nucleic acids

Nektar Therapeutics · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916184

Artificial tissue systems and uses thereof

UNIVERSITY OF CONNECTICUT · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916596

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916549

Thienooxazepine derivative

Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916519

Influenza A virus vaccines and inhibitors

The Board of Regents of the University of Texas System · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916606

Therapeutic compositions and methods for targeted delivery of active agents

The Board of Regents of the University of Texas System · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916565

Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916603

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916175

Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916580

Spiro-oxindole compounds and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916566

Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916556

Pharmaceutical formulations comprising neurotrophin mimetics

The United States of America represented by the Department of Vetran Affairs · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916551

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916528

Compositions containing resveratrol and nucleotides

RESVERATROL PARTNERS, LLC · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916570

A3 adenosine receptor agonists and antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916538

Solid forms of a thiophosphoramidate nucleotide prodrug

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916529

Oligonucleotide-containing pharmacological compositions and their use

Lakewood Amedex, Inc. · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916197

Bone marrow-directing drug delivery materials and their applications

The Board of Regents of the University of Texas System · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916172

MVA expressing modified HIV envelope, gag, and pol genes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8916159

Selenocysteine mediated hybrid antibody molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2014378455

NEW USE OF 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

ACRAF [IT] · Granted Thu Dec 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921097

Methods for expression and purification of immunotoxins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920854

Oral care compositions for treating xerostomia

Georgia Regents Research Institute, Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920373

Reduced volume formulation of glatiramer acetate and methods of administration

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921050

Methods of diagnosing renal cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921354

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920799

Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921071

Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920867

Methods of forming self-supporting films for delivery of therapeutic agents

Covidien LP · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920840

Enteric tablet

Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920800

Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920848

Use of cellular extracts for skin rejuvenation

REGENICS AS · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920812

Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

Takeda Vaccines, Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920807

Vault complexes for cytokine delivery

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8920625

Electrochemical method of making porous particles using a constant current density

The Board of Regents of the University of Texas System · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921335

Oral delivery of nucleic acid-based gene interfering agents by Salmonella

The Regents of the University of California · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921326

Sustained-release composition and method for producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8921348

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

Corcept Therapeutics Incorporated · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)